A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

NCT00038961 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1309

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism

Interventions

DRUG: fondaparinux sodium
OTHER: placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]